TCL Archive Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039. March 1, 2002
TCL Archive Ohio Plans To Build Four New Cancer Centers With $140 Million Bond Issue If Voters Approve February 21, 1975
TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999
TCL Archive In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind January 23, 1976
